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Summary 
Generation of coagulation  factor Xa by the intrinsic pathway protease complex is essential for 
normal activation of the coagulation cascade in vivo. Monocytes and platelets provide membrane 
sites for assembly of  components of this protease complex, factors IXa and VIII. Under biologically 
relevant conditions, expression of functional activity by this complex is associated with activation 
of factor VIII to VIIIa.  In the present studies, autocatalytic regulatory pathways operating on 
monocyte and platelet membranes were investigated  by comparing the cofactor function of thrombin- 
activated factor VIII to that of factor Xa-activated factor VIII. Reciprocal functional titrations 
with purified human factor VIII and factor IXa were performed at fixed concentrations of human 
monocytes, CaC12, factor X, and either factor IXa or factor VIII. Factor VIII was preactivated 
with either thrombin or factor Xa, and reactions were initiated by addition of factor X. Rates 
of factor X  activation were measured using chromogenic substrate specific for factor Xa. The 
KIA values, i.e., concentration of factor VIIIa at which rates were half maximal, were 0.96 nM 
with thrombin-activated factor VIII and 1.1 nM with factor Xa-activated factor VIII. These values 
are close to factor VIII concentration in plasma. The Vsat, i.e., rates at saturating concentrations 
of factor VIII, were 33.3 and 13.6 nM factor Xa/min, respectively. The K1/u and Vsat values 
obtained in titrations with factor IXa were not significantly different from those obtained with 
factor VIII. In titrations with factor X, the values of Michaelis-Menten coefficients (Km) were 
31.7 nM with thrombin-activated factor VIII, and 14.2 nM with factor Xa-activated factor VIII. 
Maximal rates were 23.4 and 4.9 nM factor Xa/min, respectively. The apparent catalytic efficiency 
was similar with either form of factor VIIIa. Kinetic profiles obtained with platelets as a source 
of membrane were comparable to those obtained  with monocytes.  These kinetic profiles are 
consistent with a 1:1 stoichiometry for the functional interaction between cofactor and enzyme 
on the surface of monocytes and platelets. Taken  together, these results indicate that autocatalytic 
pathways connecting the extrinsic,  intrinsic,  and common coagulation  pathways can operate 
efficiently on the monocyte membrane. 
,•  ctivation of the coagulation cascade is mediated by mem- 
brane-dependent protease complexes historically grouped 
into three different pathways: extrinsic, intrinsic, and common. 
The monocyte/macrophage, a central element in the inflam- 
matory response, has been shown to provide appropriate mem- 
brane sites for efficient assembly of coagulation proteases. Ki- 
netic and functional characteristics  of monocyte-mediated 
reactions of the extrinsic and common coagulation pathways 
have been examined in detail before (1-7). In contrast, little 
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information is available on kinetic characteristics of intrinsic 
pathway reactions mediated by monocytes. These reactions 
include autocatalytic  loops  that connect the extrinsic  and 
common pathways and that, potentially, regulate fibrin depo- 
sition during inflammatory,  neoplastic, atherosclerotic, and 
degenerative processes. The monocyte is the only blood cell 
type capable of promoting activation of both extrinsic and 
common pathways at biologically relevant rates. Therefore, 
to better understand the role of monocytes in coagulation, 
it is important to determine whether the autocatalytic coagu- 
lation loops can operate efficiently at the level of the mono- 
cyte membrane. 
Activation of coagulation factor X via the intrinsic pathway 
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formed by a protease component, factor IXa, and an essential 
cofactor, factor VIIIa (8-10). This cofactor is synthesized as 
a single polypeptide with 2351 residues, but it is recovered 
from plasma as a heterogeneous mixture of polypeptides with 
molecular weights ranging from 80 to 210 kD (11, 12). Equi- 
librium binding studies of factor VIII interaction with platelet 
membranes  and with  artificial  lipid vesicles  have yielded a 
dissociation  constant  (Ka)  of 2-4  nM  (13,  14).  It  is  also 
known that interaction between factors VIII and IXa on a 
lipid membrane  is indispensable for expression of biologi- 
cally significant coagulant activity (8-10). In functional titra- 
tions, concentrations of factor IXa required to achieve half- 
maximal rates of factor X activation on platelets were found 
to be 0.5 nM (8). The value of this functional parameter is 
close to the Ka determined in equilibrium binding  experi- 
ments (10). The corresponding functional parameter for factor 
VIII has not been determined. 
Conversion of circulating  factor VIII into the active cofactor, 
factor VIIIa, is mediated by specific proteolytic cleavages cata- 
lyzed by either thrombin  or activated factor X,  factor Xa. 
In turn,  thrombin  and factor Xa are generated by specific 
proteolysis via the common and extrinsic pathway, respec- 
tively. Thus, the extrinsic and common coagulation pathways 
converge at the level of factor VIII. Thrombin and factor Xa 
cleave human factor VIII at Arg372-Ser373, Arg740-Ser741, 
and Arg1689-Ser1690 positions, giving subunits of 73, 51, 
and  43  kD.  Factor  Xa also cleaves factor VIII at  position 
Arg1721-Ala1722,  giving a 67-kD fragment that is unique 
to processing by factor Xa (15, 16). Further cleavages by pro- 
tein C,  factor Xa,  and perhaps  thrombin  are  associated to 
progressive disappearance of the biological activity of factor 
VIIIa (15).  The possibility of spontaneous,  nonproteolytic 
inactivation of factor VIIIa has  also been indicated (16).  In 
artificial  membrane systems, enzyme complexes with factor 
VIIIa{t) (thrombin-activated  factor VIII)  appear  to express 
levels of activity different from those expressed by complexes 
with factor VIIIixa ) (factor Xa-activated factor VIII) (15-17). 
It is not known whether  this difference in activity results 
from differences in catalytic rates between the two forms of 
the enzyme complex or from differences in the efficiency of 
complex formation. There is no information available about 
the relative efficiency of the two forms of the enzyme when 
assembled on cell membranes. 
We have shown previously that blood monocytes and al- 
veolar macrophages but no other nucleated blood cell types, 
can provide appropriate lipid cofactor for assembly of intrinsic 
pathway  components  when  factor  VIIIalxa)  is  present  as 
cofactor (18).  In the present studies we derived parameters 
characterizing  the functional association of factor VIII to factor 
IXa on monocyte and platelet membranes, and compared ki- 
netics of factor X  activation by either factor IXa/VIII{t), or 
factor IXa/VIIIa~x~)  complexes. 
Materials and Methods 
Cell Isolation and Characterization.  Human mononudear cells 
were purified from peripheral blood using Ficoll-Hypaque as pre- 
viously described (19). Mononuclear  cells were further  enriched 
for monocytes by centrifugation  through hypertonic Percoll (48- 
50% Percoll in 1% NaC1), layered under isosmolar culture medium 
(M199  supplemented  with  0.5%  heat-inactivated  lactalbumin 
hydrolysate, 100 U/m1 penicillin, and 100 ~g/ml streptomycin). 
Cells were washed at least twice with 0.85% NaCI containing 0.1% 
EDTA, and at least once more with culture  medium.  Extensive 
washing was necessary to completely deplete the preparation  of 
platelets. Purity of the cell preparation  was determined by mor- 
phologic examination of cytocentrifuge preparations either stained 
with Wright's stain or processed histochemically for nonspecific 
esterase using ol-naphtbyl acetate as substrate (20). The cell prepa- 
rations contained 85-95% monocytes, 5-15% lymphocytes, and 
=2% PMN. 
Platelets separated during monocyte purification were processed 
like the monocyte-rich population  and used for comparison in ki- 
netic studies. Platelets were also isolated in a resting state by gel 
filtration (21, 22). For kinetic measurements, these platelets were 
fully activated with 1 #M ionophore A23187 for 5 rain at 37~ 
as described before (23). At this concentration, A23187 was shown 
to induce maximal procoagulant activity in human platelets in the 
absence of cell lysis, as indicated by lack of lactate dehydrogenase 
release (23). 
The platelet content of the monocyte population was monitored 
routinely by careful morphologic examination under light micros- 
copy. In addition,  representative preparations were processed for 
electron microscopy and immunostained  with mAbs specific for 
platelet IIb/IIIa glycoprotein  (21). 
Immunostaining and Electron MicroscoI~.  Purified  monocyte prepa- 
rations were assayed  ultrastructurally for whole platelet and platelet 
membrane fragment contamination by immunoblot cytochemistry. 
For  these  studies,  cells were  fixed in  suspension with  2.5% 
glutaraldehyde, 0.1 M cacodylate buffer (pH 7.35), for 10-15 rain 
and pelleted at 1,000g for 2 min. The monocytes were then rinsed 
in Gey's buffer (Gibco Laboratories, Grand Island, NY) (pH 7.3), 
followed by three rinses in Gey's containing 01% glycine to quench 
free aldehydes and reduce nonspecific  antibody binding. After rinsing 
once more with glycine-free Gey's buffer, 50 #t of routine mono- 
clonal anti-GP IIb/IIIa antibody P2 (AMAC Inc., Westbrook, ME) 
was added to the monocyte at a final IgG concentration of 10/zg/ml. 
This antibody is specific  for platelet membranes and shows no cross- 
reactivity with monocytes (21, and this report). Rabbit polyclonal 
antihuman  lactoferrin antibodies (Organon-Teknika Corp.,  West 
Chester,  PA) were used (at a total protein  concentration  of 100 
#g/ml) as a control for nonspecific  primary antibody binding. After 
a 45-rain incubation at 220C with the primary antibodies, cell pellets 
were rinsed three times in Gey's buffer, and 50-100 #1 of a mixture 
of species-specific secondary immunogold  probes  (Janssen Life 
Science, Olen, Belgium) was incubated with the pellets for 60 min 
at 22~  This secondary gold probe mixture consisted of 15 nM 
goat anti-mouse IgG and 5 nM goat anti-rabbit  IgG (as an in- 
ternal immunogold control)  mixed 1:1 (vol/vol) and diluted  1:2 
in Gey's buffer. The pellets were subsequently rinsed three times 
in Gey's buffer and once in 0.1 M cacodylate, and postfixed in 1% 
OSO4/0.1 M cacodylate for 20 rain at 22~ 
Monocyte pellets were stained with uranyl acetate and lead ci- 
trate and observed on a transmission electron microscope (TEM) 1 
(model 400; Philips, Mahwah,  NJ) at magnifications of 9,000- 
25,000. Platelet suspensions obtained during monocyte purification 
were also processed for TEM without subjecting the cells to im- 
munostaining  procedures. 
1 Abbreviation used in this paper: TEM, transmission electron microscope. 
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<3,000 U/mg of protein was obtained from Armour Pharmaceu- 
tical Company (Kankakee, IL). Purity and electrophoretic charac- 
teristics of this protein have been documented before (24, 25). 1 U 
of factor VIII is equivalent to factor VIII activity present in 1 ml 
of normal human plasma. Purified human factors X and IXa with 
sp act of 125-200 and 200 U/mg of protein, respectively, were ob- 
tained from Enzyme Research Laboratories Inc. (South Bend, IN), 
Factors X and IXa (factor IX activated with factor XIa) were elec- 
trophoretically and functionally pure as determined by SDS poly- 
acrylamide dectrophoresis and in coagulation tests. Factor Xa was 
generated from factor X using Russell's viper venom as previously 
described (26, 27). Concentrations of  factor Xa and thrombin used 
for factor VIII activation were standardized routinely using spedfic 
chromogenic substrates S-2222 (N-Benzoyl-L-isoleucyl-L-glutamyl- 
glycyl-t-arginine-/~-nitroanilide  hydrochloride) and S-2238  (H-D- 
Phenylalanyl-L-pipecolyl-L-arginine-/~-nitroanilide  hydrochloride), 
respectively (Kabi  Diagnostics,  Helena Laboratories,  Beaumont, 
TX). A rate of 0.05 absorbance U/rain was obtained with 0.035 
U/ml of thrombin. A rate of 0.006 absorbance U/min was ob- 
tained with 1 nM of factor Xa. Thrombin (2,720 National Insti- 
tutes of Health (NIH) U/rag)  was  a generous gift from Dr. J. 
Fenton, The Albany Medical College of Union University, Albany, 
NY.  For calculation of molar concentrations of factor VIII used 
in  titration  experiments  1 U/ml  of this  factor was  equated to 
I nM (17). 
Measurement of Factor X  Activation Rates on Monocytes.  Initial 
rates of factor X activation were measured using incubation mix- 
tures containing ce/ls" 2.8  x  106/mt; CaC12, 5 raM; and purified 
human factors  IXa, VIII, and X  at the concentrations indicated 
for each type of experiment. Factor VIII was fully converted to 
the cofactor form, factor VIIIa, by including either thrombin or 
factor Xa in the mixtures. Reagents were in "Iris buffer 0.15 N 
NaCI pH 7.3 and reactions were initiated with the substrate factor 
X. After addition of substrate, 40-/~1 samples were taken every 30 
sec for 3.5 min. Concentrations of factor Xa in each sample were 
determined with specific factor Xa chromogenic substrate, at 0.3 
mg/ml in Tris buffer, 0.25 N  NaC1 pH 8.3 (27).  Initial rates of 
chromogenic substrata hydrolysis were followed at 405 nM using 
a Vmax kinetic microplate reader (Molecular Devices Corp., Menlo 
Park, CA). 
Initial rates were calculated by linear regression of  factor Xa con- 
centration over time using graphic methods and the computer pro- 
gram Enzfitter (Elsevier-Biosoft, Cambridge, UK). Rates of factor 
Xa generation over time were also calculated by fitting the ex- 
perimental progression curves to polynomial equations such  as 
[Xa]t =a+bt+ct 2, where [Xa]t is the concentration of Xa formed 
at time t. By differentiating the resulting equations, d(Xa)/dt  = 
b + 2ct at t  =  0, d(Xa)/dt  ~  b, the initial rate is equivalent to the 
linear coefficient. Fitting of polynomial equations was done using 
the  computer  program  Stat-View  512+  (Brain  Power,  Inc., 
Calabasas, CA). For functional titrations" factor VIII, factor IXa, 
or factor X concentrations were varied, while other components 
were kept constant. Initial rates  were plotted against concentra- 
tions of either factor VIII, IXa, or X, and rectangular hyperbolas 
were fitted to  the data using  the computer program Enzfitter 
(Elsevier-Biosoft).  For monocytes and centrifuged platelets' stan- 
dard errors of kinetic parameters obtained in each fitting were 1-15% 
of the parameter value. Except where indicated, all experiments 
used to determine kinetic parameters were repeated at least three 
times. 
For interpretation of these rate measurements, it was assumed 
that components oftbe factor X activating complex (calcium, factors 
IXa and Villa, and membrane) were at equilibrium, and that addi- 
tion of substrate did not affect this equilibrium. This assumption 
is justified by results of experiments, (described  below) designed 
to  determine  optimal  initial  conditions.  In  these  experiments 
prolonging preincubation periods before initiating reactions with 
substrate did not result in significant changes of subsequent initial 
rates. 
Interpretation of initial rate measurements was done within the 
hypothetical framework of a one-enzyme, one-substrate, reaction, 
the basic mechanism of which can be represented as: 
(IXa/VIIIa) +X~  k2  _  (IXa/VIIIa).X~Xa, 
where, (IXa/VIIIa) is the membrane bound enzyme. This com- 
plex is formed by specific interactions between factor IXa and factor 
VIIIa on membrane phospholipids" in the presence of caldum ions. 
The expression (IXa/VIIIa).X  represents  the membrane-bound 
enzyme-substrate complex. In this scheme,  binding of factor X 
to (IXa/VIIIa) is reversible, and kl and k-1 are the rate constants 
for the association  and dissociation reactions.  The rate constant 
of product formation from the substrate-enzyme complex is k2. 
The membrane lipids, calcium and factor VIIIa, are considered to 
be essential  activators.  That is, the enzymatic component factor 
IXa does not exhibit biologically relevant activity unless it is bound 
to membranes in the presence of factor VIIIa and calcium (8). This 
was the case for the range of  concentrations and observation intervals 
of the present experiments. During steady state,  i.e.,  the period 
in which overall rates of product formation are linear, the concen- 
tration of (IXa/VIIIa).X is assumed to be constant, and the cata- 
lytic efficiency (k,,/Km) of the reaction is ktk2/(k-~+k2). 
Previous studies by others, using platalets (28), have established 
that bound factor IXa is a small fraction of the total amount in 
mixtures. Consequently, at the cell and reagent concentrations used 
in these studies,  the substrate in the bulk phase was always at a 
great molar excess over concentration of bound functional factor 
IXa/VIIIa complexes.  The term functional interaction is used to 
indicate reactions on the membrane that result in detectable rates 
of factor X  activation under the specified conditions. Thus, pos- 
sible molecular interactions between factors IXa, VIII, and X  in 
the bulk phase are ignored since only a negligible amount of  product 
is produced in the absence of cells. 
Standardization of  Initial Conditions.  The reaction of interest in 
these studies  was the activation of factor X by factor IXa/VIIIa 
complexes on monocytes. Therefore, it was important to demon- 
strate that the concentration of  functional activating complexes re- 
mained constant for the duration of the rate measurements. Also, 
since one of the objectives of these studies was to functionally com- 
pare thromhin-activated factor VIII (factor VIII%)) to factor Xa- 
activated factor VIII (factor VIIIa~x,)), these preliminary experi- 
ments were designed to insure that activity of both forms of the 
cofactor was maximal during measurements. Additionally, since 
extensive proteolytic  cleavages of  factor VIII by both activators have 
been shown to be associated with loss ofprocoagnlant activity (15), 
it was necessary to find the lowest concentration of activator, and 
the shortest activation times resulting in complete activation of 
the cofactor. 
To determine the time required to achieve maximal activation 
of factor VIII, this factor at 1 U/ml was preincubated with calls" 
2.8  x  106/ml;  CaCI2,  5 raM;  factor IXa, 0.75 nM,  and either 
0.8 nM of factor Xa or 0.05 U/m1 (--0.45 nM) thrombin. Prein- 
cubation time was varied from 0--9 rain in reaction mixtures con- 
taining  factor Xa,  and  from 0-4  min  in  mixtures  containing 
thrombin. After preincubation periods, reactions were initiated by 
addition of 140 nM of factor X, and the concentration of factor 
29  McG~ et al. Xa was determined in sequential samples with S-2222 chromogenic 
substrate, as indicated above. The length of presteady-state or lag 
time was estimated by extrapolation of the steady-state regression 
line to the abscissa in plots of factor Xa concentration versus time. 
Steady-state rates were determined from the slope of straight lines 
fitted to experimental points manually, and by using a computer 
program for regression analysis  as indicated  above. 
Lag times were inversely correlated with the length of the prein- 
cubation period, and were much shorter for thrombin than for factor 
Xa.  After  these  lags,  rate  of  factor  X  activation  was  linear. 
Prolonging preincubation periods up to 9 rain in mixtures with 
Xa, and up to 3 rain in mixtures with thrombin did not change 
initial rates significantly.  Thus,  after 0.5 min of incubation with 
thrombin and 4 min with factor Xa, factor VIII activation was 
maximal and remained constant for at least 3 and 9 rain, respec- 
tively. In all subsequent kinetic experiments, sampling of reaction 
mixtures was kept within  these time limits. 
The effect of either factor Xa or thrombin concentration on lag 
times was determined using reaction mixtures constructed as above, 
but with concentrations of factor Xa ranging from 0.2 to 1.6 nM, 
and concentrations of thrombin ranging from 0.05 to 0.65 U/ml 
(0.45-5.8 nM). Preincubation intervals were kept at 4 and 0.5 min, 
respectively.  The length of the lag periods was inversely correlated 
with the concentration of activating enzyme. At physiologic con- 
centrations of factor VIII, 1 U/ml, no lags were detected at any 
of the thrombin concentrations  tested. Lags were also  abolished 
with concentrations of factor Xa >0.3 nM. After lag periods, ini- 
tial rates of factor X  activation were the  same regardless  of the 
concentration of either factor Xa or thrombin used to preactivate 
factor VIII. Postlag linear rates of factor X  activation in mixtures 
with  1 and 0.2 U/ml of factor VIIIa~t) were 25  and 8 nM factor 
Xa/min, respectively.  In mixtures with factor VIIIa~x,), rates were 
6.6 and 2.3 nM factor Xa/min. Results of these factor VIII activa- 
tion experiments in the presence of monocytes are very similar to 
results with platelets reported in detail by other investigators (17). 
Protein and Lipid Measurements.  Protein determinations were per- 
formed with reagent (Biorad Laboratories, Richmond, CA), using 
BSA as standard. Cell lipid extraction and lipid phosphorus deter- 
minations were performed as described before (29, 30). Mean lipid 
phosphorus content was 6.6  _+ 0.57, and 5.1  +  0.9 nmol for five 
paired samples with 106 monocytes and 107 platelets, respectively. 
Mean protein content  was 29.04  +  3.7 #g,  and  7.7  +_  1.3/xg, 
respectively. 
Figure 1.  Differential staining of human monocytes and platdets with anti-IIb/IIla specific  mAbs. Bound antibodies were detected with gold-labeled 
secondary antibodies (see Materials and Methods). Arrows point to a platelet that is positively stained. In contrast,  monocyte membranes show no 
label. The proportion of whole, positively-stained  platelets was 19/200, i.e., 9.5%. Picture also shows (arrow, top left) a typical example of the positively- 
stained membrane fragments, found associated with some of the cells. These fragments are =0.18 ~m in diameter, and have a surface area estimated 
to be <0.02%  of the surface area of a typical monocyte of 15/zm diameter. Magnification  ~  18,900. 
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Determination of  Monocyte Population Purity by Immunostaining 
and Electron Microscope Examination.  The platdet membrane 
is known to express sites for very e~cient activation of factor 
X by factor IXa/VIIIa (8). Since platelets are frequently coiso- 
lated with monocytes when using standard cell isolation proce- 
dures,  it was essential to exclude significant contamination 
with either whole platelet  or platelet membrane fragments 
of the monocyte preparation.  This was achieved using im- 
munogold staining with specific anti-G-P lib/Ilia mAbs and 
electron  microscope examination  as  explained  in Materials 
and  Methods.  Fig.  1  illustrates  the  specificity  of the  im- 
munogold staining for the platelet  membrane.  The mono- 
cytes were also examined for positively stained membrane frag- 
ments. 120 of 200 randomly-selected monocyte profiles,  (60%) 
were negative for any associated positively-staining membrane, 
while the remaining 80 (40%) were associated with one or 
occasionally two fragments that measured =0.18 #m in di- 
ameter. From these measurements, we estimated that the sur- 
face of each one of these particles  corresponds to <0.02% 
of the surface area of a typical monocyte of 15 #m diameter. 
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Figure 2.  Functional titration of factors Villa and IXa on monocytes. 
Initial rates of  factor X activation were measured as indicated in Materials 
and Methods and Table 1. Data are mean from three titration experiments 
with either factor VIlla(xa) (O),  or factor IXa (O). 
The  proportion  of whole  positively-stained  platelets  was 
19/200, i.e., 9.5%, confirming routine observations with light 
microscopy. 
Platelets separated from the mononuclear cells by differen- 
Table  1.  Factor  X  Activation by Factor IXa/VIIIa  on Monocytes: Functional Titration with Factors Villa and IXa 
Titration  with factor Villa*  Titration with factor IXa* 
Factor VIII  Vsat  Vsat 
activators  K1/2 II  FXa/min  KIA  FXa/min 
nM 
Factor Xa  1.10  _+  0.14  13.6  _+  2.1  1.02  _+  0.16  12.7  _+  1.3 
Thrombin  0.96  _+  0.18  33.3  _+  1.9  0.64  _+  0.14  36.8  -+  3.6 
* Initial rates of factor X activation were measured in reaction mixtures with fixed concentration of cells 2.8  x  106/ml; CaCI~, 5 mM,  factor 
IXa, 0.75  riM,  factor X,  140 nM,  and factor VIII concentrations ranging from 4  to 0.031  U/ml (1  U/ml  =  1 nM). 
* Factor IXa was titrated in reaction mixtures prepared as above, except that factor VIII concentration was kept at 1 U/ml, and factor IXa concen- 
tration was varied from 0.12 to 15 nM. 
S Factor VIII was activated with either factor Xa, 0.8 riM, or thrombin,  0.05 U/ml, as indicated in Materials and Methods. 
II Parameters KIA (concentration of either factor VIlla or IXa at which initial rates were half of maximum) and Vsat (rates at saturating concentra- 
tion of either factor VIIIa or IXa) were calculated by fitting data to rectangular hyperbolae using a computer program. Data are mean _+ SE of 
three experiments, each with cells from a different donor. 
Table  2.  Factor  X  Activation by Factor IXa/VIIla  on Platelets Isolated by Centrifugation: Functional Titration 
with Factors VIIIa  and IXa 
Titration  with  factor Villa*  Titration with  factor IXa 
Factor VIII  Vsat  Vsat 
activator  K1/2  FXa/min  K1/2  FXa/min 
nM 
Factor Xa  1.10  +  0.15  14.8  _+  8.6  0.70  +  0.09  14.4  +  1.2 
Thrombin  1.07  _+  0.26  30.3  +  4.0  0.79  +_  0.09  32.1  _+  2.4 
* Initial rate measurements and calculation of parameter values were as indicated in Table 1. Platelet concentration was 28  x  106/ml. Data are 
mean _+ SE of three experiments, each done with  platelets from a different donor. 
31  McGee  et al. tial centrifugation were also examined under TEM before the 
immunostaining procedure. By morphologic criteria, these 
platelets appeared partially activated as evidenced by charac- 
teristic shape changes and degranulation. 
Factor X  Activation by Factor IXa/VIIIa on Monocytes. Func- 
tional Titration with Factors VIIIa and IXa.  To characterize 
the relationship between factor IXa and VIIIa concentration 
and initial rates of factor X activation, reaction mixtures were 
titrated with factor IXa and VIIIa. Factor X activation rates 
were  measured  at  fixed  concentrations  of  cells,  2.8  x 
106/ml; CaC12, 5 mM; either factor IXa or factor VIII, and 
factor X, 140 riM. For titrations with factor IXa, concentra- 
tions were from 0.12-1 riM, and factor VIII was kept at 1 
U/ml. For titrations with factor VIII, concentrations were 
from 0.03 to 4 nM,  and factor IXa was kept at 0.75 riM. 
Factor VIII was activated optimally with either 0.8 nM factor 
Xa, or 0.05 U/ml (0.45 riM) thrombin added 4 and 0.5 min, 
respectively, before initiating reactions with factor X. Enzy- 
matic mixtures with factor VIIIa(t) or factor VIIIa~xa) were 
prepared and assayed simultaneously to minimize experimental 
variability. 
Rates of factor X activation increased with factor IXa and 
VIIIa concentration and approached to a maximum asymp- 
toticaUy (Fig. 2).  Apparent activation parameters are sum- 
marized in Table 1. 
Factor X  Activation by Factor IXa/VIIIa on Platelets. Func- 
tional Titrations with Factors VIIIa and IXa.  Initial rate mea- 
surements and calculation of kinetic parameters were also per- 
formed in platelets.  Reagent concentrations and experimental 
conditions were as indicated for monocytes; the platelet con- 
centration in these experiments was 28  x  106/ml.  Results 
in Tables 2 and 3 show that kinetic parameters on platelets, 
activated by either centrifugal force or by A23187, are similar 
to these obtained with monocytes. 
The induction of factor IXa/VIIIa assembly sites on platelets 
by A23187 was investigated in cells from six different donors. 
In these experiments, concentrations were gel-filtered platelets, 
28  x  106/ml;  factor IXa, 0.8 nM; factor VIIIa, 1 nM, and 
factor X, 70 nM. Initial rates were measured in paired reac- 
tion mixtures preincubated for 5 rain at 37~  in either the 
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Figure 3.  Factor  X activation  by factor  IXa/VIIIa assembled  on mono- 
cytes. Comparison  between  factor  Xa-activated  and thrombin-activated  factor 
VIII. Initial rates of factor  X activation  were measured  in reaction  mix- 
tures constructed  as indicated  in Materials and Methods. Factor  VIII con- 
centration was fixed at 1 U/ml, and factor X concentration  was varied 
from 1.1 to 140 riM. Factor VIII was activated  with either factor  Xa (O) 
or thrombin  (e). Data are from one of eight experiments,  each  with cells 
from a different  donor. Mean and standard errors for these experiments 
are in Table 4. 
presence or absence of 1 #M A23187. Initial rates were 10.3 
+  4.2 and 0.65  _+ 0.2 nM factor Xa/min on stimulated and 
resting platelets, respectively. Measured under identical con- 
ditions, the rates on platelets activated by centrifugation were 
11.1  _+  2.6 nM factor Xa/min. Thus, although centrifuged 
platelets are partially activated by morphologic criteria, they 
appear to be fully activated with respect to procoagulant ac- 
tivity. 
Kinetic Parameters of Factor X  Activation on Monocytes and 
Platelets. Comparison between IXa/VIIIa~xa~ and IXa/VIIIa~t) 
Complexes.  The results from titrations with enzyme com- 
ponents indicate higher Vsat with factor VIII(o than with 
factor VIIIa(xa), but similar K1A values. This suggested that 
the catalytic rate of enzymatic complexes in mixtures with 
factor VIIIa(t) is higher than in mixtures with factor VIIIa(x~). 
Table 3.  Factor  X  Activation by Factor IXa on Gel-filtered Platelets Activated with Ionophore: Functional Titration 
with Factors VIIIa, IXa, and X 
Titration with  Titration with  Titration with 
factor Villa  factor IXa  factor X 
Factor VIII  Vsat  Vsat  Vmax 
activator  Kl/z  FXa/min  K1/z  FXa/min  Km  FXa/min 
nM 
Factor Xa  0.56  18  0.87  23  27  22 
Thrombin  0.76  39  0.43  30  64  38 
Platelets were isohted by gel filtration  and activated  with 1/xM ionophore  A23187. Concentrations,  initial rate measurements, and kinetic parameters, 
determination were as indicated in Tables 1 and 2. Data are means of two experiments, each with platelets from a different donor. 
32  Monocyte-mediated  Assembly of Intrinsic Coagulation Proteases Table  4.  Kinetic Parameters of Factor X  Activation  on Monocytes and Platelets Isolated by Centrifugation: Comparison between 
IXa/VIIIa~x~j and IXa/VIIIactj Complexes 
Monocytes"  Platelets 
Factor VIII  Vmax'  Vmax' 
activator  Km'*  FXa/min  Km'  FXa/min 
nM 
Factor  Xa  14.2  _+ 3.0  4.9  •  0.8  17.9  +_ 0.09  13.4  _+  1.7 
Thrombin  31.7  _+ 5.8  23.4  _+ 4.1  45.15  +  7.6  32.8  +  6.9 
p  =  0.004  (8)s  p  =  0.002  (8)  p  =  0.03  (3)  p  =  0.03  (3) 
* Initial rates of factor X  activation were measured in reaction mixtures prepared as indicated in Materials and Methods and Tables 1 and 2, Factor 
X  was included at concentrations ranging from 1.1 to  140 nM.  Monocytes were at 2.8  x  106/ml, and platelets at 28  x  106/ml. 
* Kinetic parameters Km' and Vmax' (apparent Km and Vmax) were calculated  by fitting Michaelis-Menten equation to data using the computer 
program Enzfitter. 
S Data are mean  +_  SE of number of experiments indicated in parenthesis, Probability values for the difference between kinetic parameters with fac- 
tor VIIla(x~) versus factor VIIIa(0 were estimated using Student's t test for paired samples.  These sets of experiments with monocytes and platelets 
were not paired, i.e.,  each cell type was obtained from a different donor. 
It was therefore interesting  to compare the rate-concentra- 
tion  relationship  of factor X  activation with  either  factor 
VIIIa(t)  or factor VIIIa(xa)-Containing  complexes.  For these 
experiments, concentrations of factors VIII and IXa were fixed 
at 1 U/ml,  and 0.75 nM, respectively. Factor X  concentra- 
tion was varied from 1.1 to 140 nM. Concentrations of cells 
and calcium were as indicated above. As in titration experi- 
ments  with  factors  IXa  and  VIII,  mixtures  with  either 
VIIIa(t)  or  VIIIa(x~) were prepared  and  assayed  simultane- 
ously. Initial rates were linear  and increased with factor X 
concentration approaching asymptotically to a maximum (Fig. 
3). Apparent kinetic parameters Kin' and Vmax' were esti- 
mated by fitting data to the Michaelis-Menten equation using 
Enzfitter  (Elsevier-Biosofr). The value of Km' was 14.2  _+ 
3,0 nM in mixtures with factor VIIIa(x~), and 31.7  +  5.6 
nM  in  mixtures  with  factor  VIIIa@  The  corresponding 
values were Vmax' of 4.9 +_ 0.8 and 23.4  -!-_ 4.1. Differences 
in both Km' and Vmax' using each activator were consistent 
in eight experiments, each with cells isolated from different 
donors. Results with platelets were similar (Tables 2, 3, and 4). 
Discussion 
In the present  studies we examined kinetics of factor X 
activation by components of the intrinsic  coagulation pathway 
assembled on the membrane of blood monocytes and platelets. 
Functional titrations with highly purified human factors VIII 
and IXa were performed using reaction mixtures containing 
fixed concentrations of monocytes and of calcium and physi- 
ologic concentrations  of factor X.  Under these conditions, 
the concentration of factors VIII and IXa, giving half-maximal 
rates of activation,  was similar to plasma concentration  of 
factor VIII,  and close to the recently reported dissociation 
constant for factor IXa interaction with platelet membranes 
(8). The K'A and Vsat values obtained in reciprocal titrations 
of factors IXa and VIIIa were equivalent within experimental 
error. These results are consistent with hypothetical assembly 
mechanisms proposed by other investigators (10),  and sug- 
gest a 1:1 molecular ratio for the functional interaction be- 
tween factors IXa and VIII on the platelet membrane. 
The KtA values of reactions with thrombin-activated factor 
VIII were similar  to the K'A  of reactions with factor Xa- 
activated factor VIII.  In contrast,  Vsat values and maximal 
rates of activation in factor X titration experiments were two- 
to fourfold higher in mixtures  with factor VIIIa(t) than  in 
mixtures  with  VIIIa(x,).  Considering  that  titrations  were 
performed  under  identical  experimental  conditions,  these 
results  also  indicate  that  the  k2,  i.e.,  kcat, of  factor 
IXa/VIIIa(0 complexes is two- to fourfold higher than that 
of factor IXa/VIIIa(x,) complexes. Since values of apparent 
Km were two- to threefold lower with factors IXa/VIIIa(x,) 
than with factors IXa/VIIIa(t),  it follows that  the apparent 
catalytic efficiencies (kc,t/Km) of enzymatic complexes with 
either  form of the cofactor are similar. 
Higher  activity  of  factor  VIIIa(0  as  compared  with 
VIIIa(x~) in  systems using  artificial  lipid  and  platelets  has 
been reported by several laboratories (15-17).  In these previous 
studies, comparative functional titrations  with either form 
of the cofactor were not made, and, therefore, it was not de- 
termined whether the higher activity observed with VIIIa(0 
resulted from differences in the k~,~ or from differences in the 
efficiency of functional interaction between factor VIIIa and 
IXa (17). Our results with monocytes and platelets indicate 
a difference in the k=~ and in apparent Km for the two forms 
of the enzyme. In contrast, the efficiency of interaction with 
factor IXa is similar for both forms of factor VIII. Thus, with 
substrate fixed at  nearly  saturating  concentration,  the rate 
of factor Xa generation (normalized as a fraction of maximal 
rate)  was  the  same  for  equivalent  concentrations  of each 
cofactor species. 
The ability of monocytes to promote functional assembly 
of factor IXa/VIIIa does not appear to depend on monocyte 
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nor exposure to reaction components resulted in detectable 
morphologic changes within the time interval of kinetic mea- 
surements reported here. Further, rates of factor X activation 
on freshly isolated monocytes were similar to those on mono- 
cytes stimulated in vitro with  endotoxin  (18). 
The differential centrifugation procedures used in the present 
studies resulted in activation of platelets. This was evidenced 
by their morphologic appearance under TEM,  and by the 
fact that  no further  activation was required for expression 
of functional  factor IXa/VIIIa  assembly sites.  In contrast, 
platelets isolated by gel filtration did not promote functional 
assembly sites for the factor IXa/VIIIa complex (18).  Thus 
it is possible that isolation procedures, i.e.,  differential cen- 
trifugation and density gradients, also affect the procoagulant 
activity of monocytes. 
Subtle changes in the membrane i.e.,  exposure of phos- 
phatidylserine (31), may occur without detectable morpho- 
logic manifestations.  However, it is important  to note that 
differential  centrifugation through density gradients does not 
result in exposure of assembly sites on all blood cell types. 
Lymphocytes subjected to the same isolation procedures as 
were the monocytes did not promote functional assembly of 
factors IXa/VIIIa  (18). 
Monocytes and platelets  are the only cells  derived from 
bone marrow under physiologic conditions that are capable 
of promoting fast activation of factor X via intrinsic pathway 
components (18).  Because of their abundance,  platelets are 
likely to provide membrane sites for factor X activation during 
intravascular coagulation. However, at sites undergoing inflam- 
matory, degenerative,  and neoplastic disease,  the monocyte 
is more prevalent than the platelet. Monocytes and macro- 
phages express tissue factor during maturation  in vitro and 
in vivo (1-5) and, like the platelet, support assembly of the 
prothrombinase  reaction  (6,  7).  We  now  show  that  the 
efficiency of the functional interaction between factors IXa 
and  either  factor VIIIa~t) or  VIIIa/xa)  on  the  monocyte is 
similar to the efficiency of this reaction on platelets. There- 
fore, these results further indicate that monocytes can be im- 
portant  sources of membrane sites for functional assembly 
of the intrinsic pathway protease in the extravascular spaces. 
The demonstration of efficient activation of factor X by com- 
plexes with either thrombin or factor Xa-activated factor VIII 
also indicates that autocatalyfic regulatory pathways connecting 
the extrinsic,  intrinsic,  and common coagulation pathways 
can operate on the monocyte surface. 
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